Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

CLINICAL TRIALS PLENARY SESSION

Tuesday, May 7, 2019

11:00 AM - 11:15 AM

A Phase 3 Study of Isradipine as a Disease Modifying Agent in Patients with Early Parkinson’s disease (STEADY-PD III): Final Study Results

Tanya Simuni MD

Good find, King. Persistence pays off. It is nice to have a firm date for release of results. Maybe some of these drug companies could try that for a change. I really am looking forward to finding out the results, and my fingers are crossed. Besides my financial interest, besides my interest as scientist and physician, this is just a great story. A beaten down fighter barely hanging on gets a second chance. A long-suffering population with a critical need is saved by an unlikely hero. A $1 forgotten drug outperforms fancy, new drugs that cost ten times more. This isn't like a typical drug trial. This is more like a Rocky movie combined with a Jack Reacher novel and made by the producers of Consumer Reports. Compelling stuff.


It won't be long now. GLTA.